查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1730836

2025年杜普伊特倫攣縮症全球市場報告

Dupuytren's Disease Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年杜普伊特倫攣縮症的市場規模將出現強勁成長。預計到 2029 年將成長至 57.6 億美元，年複合成長率（CAGR）為 6.0%。預測期內的預期成長歸因於治療方案的進步、認知的提高和早期診斷、醫療保健支出的增加、微創手術的採用率的提高以及研發活動的擴大等因素。這段時期的主要趨勢包括基因治療的突破、再生醫學和幹細胞療法的進步、人工智慧診斷工具的創新、客製化矯正器具的 3D 列印的進步以及微創手術技術的持續發展。

微創治療的日益普及預計將推動杜普伊特倫攣縮症市場的成長。這些治療只需極少的切口和組織損傷，從而減少疼痛和疤痕。越來越多的患者選擇微創手術，因為與傳統手術相比，微創手術恢復更快、不適感更少、併發症風險更低。這些治療方法可以有效地幫助杜普伊特倫攣縮症患者恢復手部功能、減少攣縮並確保更快、更舒適的復健。例如，澳洲皇家外科醫學院（RACS）2023年6月的報告發現，在澳洲使用達文西平台的手術增加了12%，從2021年的17,852例增加到2022年的19,989例。因此，微創治療的使用增加是推動杜普伊特倫攣縮症市場擴張的主要因素。

杜普伊特倫攣縮症市場的主要企業正專注於臨床試驗，以開發新型的第一線緩解疾病治療方法。進行臨床試驗是為了評估新治療方法、新藥或新程序的安全性、有效性和潛在副作用。 2023 年 4 月，Ventoux Biosciences（美國）宣布針對杜普伊特倫攣縮的纖維化治療的臨床前試驗取得了積極成果，該疾病影響了約 5% 的美國人口。該公司的主要候選藥物 VEN-201 是一種重新利用的市售藥物，已證明可有效抑制小鼠模型中的皮膚纖維化。鑑於這些令人鼓舞的結果，Ventoux 已啟動一輪資金籌措以支持 VEN-201 的開發。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 - 市場 - 宏觀經濟情境 宏觀經濟情境包括利率、通膨、地緣政治以及感染疾病和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球杜普伊特倫攣縮症市場 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球杜普伊特倫攣縮症市場：成長率分析
  • 全球杜普伊特倫攣縮症市場表現：規模與成長，2019-2024 年
  • 全球杜普伊特倫攣縮症市場預測：2024-2029 年及 2034 年規模與成長
  • 全球杜普伊特倫攣縮症總目標市場（TAM）

第6章市場區隔

  • 全球杜普伊特倫攣縮症市場（按疾病類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • I型
  • II型
  • III型
  • 全球杜普伊特倫攣縮症市場（按治療、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 外科手術
  • 放射治療
  • 針腱膜切開術
  • 類固醇注射
  • 酵素注射
  • 職能治療
  • 其他
  • 全球杜普伊特倫攣縮症市場（依給藥途徑、績效與預測），2019-2024 年、2024-2029 年、2034 年
  • 口服
  • 腸外
  • 其他
  • 全球杜普伊特倫攣縮症市場（按診斷、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 身體檢查
  • X光
  • 其他
  • 全球杜普伊特倫攣縮症市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 學術研究所
  • 其他
  • 全球杜普伊特倫攣縮症市場：I 型細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 經典杜普伊特倫攣縮症
  • 遺傳性杜普伊特倫攣縮症
  • 全球杜普伊特倫攣縮症市場：II 型細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 掌筋膜炎
  • 萊德霍斯病
  • 全球杜普伊特倫攣縮症市場：III 型細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 加羅德墊片
  • 佩羅尼氏症

第7章 區域和國家分析

  • 全球杜普伊特倫攣縮症市場各地區表現及預測（2019-2024、2024-2029、2034）
  • 全球杜普伊特倫攣縮症市場（依國家/地區、績效及預測）2019-2024、2024-2029、2034

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 杜普伊特倫攣縮症市場：競爭格局
  • 杜普伊特倫攣縮症市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Aetna Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Mayo clinic Overview, Products and Services, Strategy and Financial Analysis
    • Penn Medicine Overview, Products and Services, Strategy and Financial Analysis
    • Mercy Health Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Endo Inc.
  • Resilience Orthopedics
  • Raleigh Orthopaedic
  • Hoag Orthopedic Institute
  • OSS Health
  • Connext Inc.
  • University of Utah Health
  • Ventoux Biosciences Inc.
  • Auxilium Pharmaceuticals
  • 31.11. Brigid Freyne MD
  • 31.12. Nantong Jinghua Pharmaceutical Co. Ltd.
  • 31.13. Sumitomo Dainippon Pharma Co. Ltd.
  • 31.14. Actiza Pharmaceutical Private Limited
  • 31.15. Spear Pharmaceuticals

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年杜普伊特倫攣縮症市場：提供新機會的國家
  • 2029 年杜普伊特倫攣縮症市場：細分市場帶來新機會
  • 2029 年杜普伊特倫攣縮症市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r34508

Dupuytren's disease, also known as Dupuytren's contracture, is a condition that affects the connective tissue (fascia) in the palm and fingers, leading to thickening and tightening. Over time, this causes the fingers to bend toward the palm, making it difficult to straighten them or perform daily tasks.

The primary types of Dupuytren's disease include Type I, Type II, and Type III. Type I is the most severe form and typically appears in individuals younger than 50. Treatment options include surgery, radiation therapy, needle aponeurotomy, steroid injections, enzyme injections, and occupational therapy, among others. These treatments can be administered through various routes, such as oral or parenteral methods. Diagnosis is conducted through physical examinations, X-rays, and other medical assessments. The condition is managed across various end-users, including hospitals, clinics, academic and research institutions, and other healthcare facilities.

The dupuytren's disease market research report is one of a series of new reports from The Business Research Company that provides dupuytren's disease market statistics, including the dupuytren's disease industry global market size, regional shares, competitors with the dupuytren's disease market share, detailed dupuytren's disease market segments, market trends, and opportunities, and any further data you may need to thrive in the dupuytren's disease industry. This dupuytren's disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dupuytren's disease market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth observed in the historical period can be attributed to factors such as a growing aging population, a higher genetic predisposition, an increasing prevalence of diabetes, rising alcohol consumption, and a greater incidence of manual labor and repetitive hand trauma.

The dupuytren's disease market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth expected during the forecast period can be attributed to factors such as advancements in treatment options, greater awareness and earlier diagnosis, rising healthcare spending, increased adoption of minimally invasive procedures, and expanding research and development activities. Key trends during this period include breakthroughs in gene therapy, advancements in regenerative medicine and stem cell therapy, innovations in AI-driven diagnostic tools, progress in 3D printing for custom orthotics, and continued development of minimally invasive surgical techniques.

The increasing popularity of minimally invasive treatments is expected to drive the growth of the Dupuytren's disease market. These treatments are performed with minimal incisions or tissue damage, leading to pain relief and reduced scarring. Patients are increasingly choosing minimally invasive options because they offer quicker recovery, less discomfort, and a lower risk of complications compared to traditional surgery. These treatments effectively help Dupuytren's disease patients by restoring hand function, reducing contractures, and ensuring a faster, more comfortable recovery. For example, a report from the Royal Australasian College of Surgeons (RACS) in June 2023 revealed a 12% increase in procedures performed using da Vinci platforms in Australia, rising from 17,852 in 2021 to 19,989 in 2022. As a result, the growing use of minimally invasive treatments is a key driver of the Dupuytren's disease market expansion.

Leading companies in the Dupuytren's disease market are focusing on clinical trials to develop novel, first-line, disease-modifying treatments. Clinical trials are conducted to assess the safety, effectiveness, and potential side effects of new medical treatments, drugs, or procedures before they are approved for widespread use. In April 2023, Ventoux Biosciences, a US-based biopharmaceutical company focused on developing non-surgical therapies for Dupuytren's disease, announced positive pre-clinical results for its fibrosis treatment targeting Dupuytren's contracture, which affects approximately five percent of the U.S. population. The company's lead candidate, VEN-201, is a repurposed commercially available drug that has shown effectiveness in reducing skin fibrosis in mouse models. This promising outcome led Ventoux to initiate a fundraising round to support the development of VEN-201.

In November 2024, John Elway, a US-based retail company, partnered with Endo Inc. to raise awareness and encourage early diagnosis and treatment of Dupuytren's contracture. The partnership aims to promote XIAFLEX (collagenase clostridium histolyticum) as a non-surgical treatment option for the condition. Endo Inc., a US-based pharmaceutical company, manufactures this medication for Dupuytren's contracture. The collaboration seeks to improve patient outcomes through better awareness and access to treatment options.

Major players in the dupuytren's disease market are Pfizer Inc., Aetna Inc., Mayo clinic, Penn Medicine, Mercy Health, Endo Inc., Resilience Orthopedics, Raleigh Orthopaedic, Hoag Orthopedic Institute, OSS Health, Connext Inc., University of Utah Health, Ventoux Biosciences Inc., Auxilium Pharmaceuticals, 180 Life Sciences Corp., Brigid Freyne MD, Nantong Jinghua Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Actiza Pharmaceutical Private Limited, Spear Pharmaceuticals.

North America was the largest region in the dupuytren's disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dupuytren's disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dupuytren's disease market consists of revenues earned by entities by providing services such as diagnosis, physical therapy, minimally invasive treatments, surgical procedures, post-treatment rehabilitation, and related pharmaceutical and medical device solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The dupuytren's disease market also includes sales of products such as collagenase injections, anti-inflammatory medications, splints, orthopedic braces, surgical instruments, and laser or ultrasound therapy devices used for treatment and management of the condition. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dupuytren's Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dupuytren's disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dupuytren's disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dupuytren's disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease Type: Type I; Type II; Type III
  • 2) By Treatment: Surgery; Radiation Therapy; Needle Aponeurotomy; Steroid Shot; Enzyme Injection; Occupational Therapy; Other Treatments
  • 3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration
  • 4) By Diagnosis: Physical Examination; X-Ray; Other Diagnosis
  • 5) By End-User: Hospitals; Clinics; Academic And Research Institute; Other End-Users
  • Sub Segments:
  • 1) By Type I: Classical Dupuytren's Disease; Familial Dupuytren's Disease
  • 2) By Type II: Palmar Fasciitis; Ledderhose Disease
  • 3) By Type III: Garrod's Pads; Peyronie's Disease
  • Companies Mentioned: Pfizer Inc.; Aetna Inc.; Mayo clinic; Penn Medicine; Mercy Health
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dupuytren's Disease Market Characteristics

3. Dupuytren's Disease Market Trends And Strategies

4. Dupuytren's Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Dupuytren's Disease Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Dupuytren's Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Dupuytren's Disease Market Growth Rate Analysis
  • 5.4. Global Dupuytren's Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Dupuytren's Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Dupuytren's Disease Total Addressable Market (TAM)

6. Dupuytren's Disease Market Segmentation

  • 6.1. Global Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type I
  • Type II
  • Type III
  • 6.2. Global Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgery
  • Radiation Therapy
  • Needle Aponeurotomy
  • Steroid Shot
  • Enzyme Injection
  • Occupational Therapy
  • Other Treatments
  • 6.3. Global Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administration
  • 6.4. Global Dupuytren's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Physical Examination
  • X-Ray
  • Other Diagnosis
  • 6.5. Global Dupuytren's Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Academic And Research Institute
  • Other End-Users
  • 6.6. Global Dupuytren's Disease Market, Sub-Segmentation Of By Type I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Classical Dupuytren's Disease
  • Familial Dupuytren's Disease
  • 6.7. Global Dupuytren's Disease Market, Sub-Segmentation Of Type II, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Palmar Fasciitis
  • Ledderhose Disease
  • 6.8. Global Dupuytren's Disease Market, Sub-Segmentation Of Type III, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Garrod's Pads
  • Peyronie's Disease

7. Dupuytren's Disease Market Regional And Country Analysis

  • 7.1. Global Dupuytren's Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Dupuytren's Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dupuytren's Disease Market

  • 8.1. Asia-Pacific Dupuytren's Disease Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dupuytren's Disease Market

  • 9.1. China Dupuytren's Disease Market Overview
  • 9.2. China Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dupuytren's Disease Market

  • 10.1. India Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dupuytren's Disease Market

  • 11.1. Japan Dupuytren's Disease Market Overview
  • 11.2. Japan Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dupuytren's Disease Market

  • 12.1. Australia Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dupuytren's Disease Market

  • 13.1. Indonesia Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dupuytren's Disease Market

  • 14.1. South Korea Dupuytren's Disease Market Overview
  • 14.2. South Korea Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dupuytren's Disease Market

  • 15.1. Western Europe Dupuytren's Disease Market Overview
  • 15.2. Western Europe Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dupuytren's Disease Market

  • 16.1. UK Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dupuytren's Disease Market

  • 17.1. Germany Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dupuytren's Disease Market

  • 18.1. France Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dupuytren's Disease Market

  • 19.1. Italy Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dupuytren's Disease Market

  • 20.1. Spain Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dupuytren's Disease Market

  • 21.1. Eastern Europe Dupuytren's Disease Market Overview
  • 21.2. Eastern Europe Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dupuytren's Disease Market

  • 22.1. Russia Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dupuytren's Disease Market

  • 23.1. North America Dupuytren's Disease Market Overview
  • 23.2. North America Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dupuytren's Disease Market

  • 24.1. USA Dupuytren's Disease Market Overview
  • 24.2. USA Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dupuytren's Disease Market

  • 25.1. Canada Dupuytren's Disease Market Overview
  • 25.2. Canada Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dupuytren's Disease Market

  • 26.1. South America Dupuytren's Disease Market Overview
  • 26.2. South America Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dupuytren's Disease Market

  • 27.1. Brazil Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dupuytren's Disease Market

  • 28.1. Middle East Dupuytren's Disease Market Overview
  • 28.2. Middle East Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dupuytren's Disease Market

  • 29.1. Africa Dupuytren's Disease Market Overview
  • 29.2. Africa Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dupuytren's Disease Market Competitive Landscape And Company Profiles

  • 30.1. Dupuytren's Disease Market Competitive Landscape
  • 30.2. Dupuytren's Disease Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Aetna Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Mayo clinic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Penn Medicine Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Mercy Health Overview, Products and Services, Strategy and Financial Analysis

31. Dupuytren's Disease Market Other Major And Innovative Companies

  • 31.1. Endo Inc.
  • 31.2. Resilience Orthopedics
  • 31.3. Raleigh Orthopaedic
  • 31.4. Hoag Orthopedic Institute
  • 31.5. OSS Health
  • 31.6. Connext Inc.
  • 31.7. University of Utah Health
  • 31.8. Ventoux Biosciences Inc.
  • 31.9. Auxilium Pharmaceuticals
    • 31.10. 180 Life Sciences Corp.
  • 31.11. Brigid Freyne MD
  • 31.12. Nantong Jinghua Pharmaceutical Co. Ltd.
  • 31.13. Sumitomo Dainippon Pharma Co. Ltd.
  • 31.14. Actiza Pharmaceutical Private Limited
  • 31.15. Spear Pharmaceuticals

32. Global Dupuytren's Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dupuytren's Disease Market

34. Recent Developments In The Dupuytren's Disease Market

35. Dupuytren's Disease Market High Potential Countries, Segments and Strategies

  • 35.1 Dupuytren's Disease Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Dupuytren's Disease Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Dupuytren's Disease Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer